Haematidrosis associated with XXXX in a @entity1 successfully treated with @entity2051 : Case report.

@entity1 @entity410 @entity548 @entity2051 @entity1503 @entity302
UNASSIGNED: The aetiology and pathological mechanisms involved in the development of haematidrosis (bloody sweat) remain unclear. There is no specific treatment for this disorder. This case report describes the clinical manifestations and treatment of a 9-year-old female with haematidrosis associated with @entity302 . The diagnosis of haematidrosis was confirmed by medical personnel who observed the @entity548 and were able to rule out other causes of the bloody exudate. The episodes of @entity548 were spontaneous, transient, and self-limited. Smears of the bloody exudate contained all of the components of peripheral blood. A skin biopsy taken at one site of the bloody exudate was normal, showing no signs of @entity1503 or @entity548 sweat glands. The @entity548 events were found to be immediately preceded by tonic @entity410 . An electroencephalogram indicated cerebral @entity302 , which was characterized by an intermittent medium-high amplitude    rhythm (5-7   Hz) with a few spikes. The symptoms of both @entity302 and haematidrosis resolved after treatment with the antiepileptic drug 150   mg @entity2051 , orally, twice a day, which suggests that the @entity302 triggered haematidrosis in this @entity1 .
